Funding uncertainty looms over lenacapavir for low-income countries despite FDA approval hopes Global Fund aims to raise $18 billion amid PEPFAR funding doubts Lenacapavir pricing crucial for access ...

Large-scale, government-led cash transfer programs drove significant improvements in health outcomes across low- and middle-income countries (LMICs), according to a major new study in The Lancet from ...

New research led by LSE reveals that high‑income countries once suffered severe child stunting comparable to rates seen in ...

Discover how tax haven governments offset low or no income taxes through customs duties, corporate fees, and departure taxes ...

Data sources PubMed, EMBASE, CINAHL and Cochrane CENTRAL. Eligibility criteria Randomised controlled trials and quasi-experimental studies published between January 2010 and September 2024. Primary ...